Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study

Yousef M Alsofayan, Saqer M Althunayyan, Anas A Khan, Ahmed M Hakawi, Abdullah M Assiri, Yousef M Alsofayan, Saqer M Althunayyan, Anas A Khan, Ahmed M Hakawi, Abdullah M Assiri

Abstract

Background: The global battle to contain the novel coronavirus disease 2019 (COVID-19) pandemic rages on. Previous studies described the clinical characteristics of COVID-19, but knowledge gaps remain in the Middle East region. Identifying these features will help in mapping the disease and guiding pandemic management. A multi-center, retrospective cross-sectional study was initiated to describe the demographic data, clinical characteristics, and outcomes of COVID-19 cases across all the regions of Saudi Arabia.

Methods: The analysis included all laboratory-confirmed positive COVID-19 patients from the 1st of March 2020 to 31st of March 2020 across all regions of Saudi Arabia. Demographic data, clinical characteristics, incubation periods, laboratory findings, and patient outcomes data were retrieved from 1519 cases in the Health Electronic Surveillance Network Database.

Results: The median age was 36 years and 54.3% (n = 825) of the patients were men. Patients working in health care facilities represented 12.5% of the cases (n = 190) and 9.3% of cases were asymptomatic. The median incubation period was 6 days. The most common symptoms were cough (89.4%), fever (85.6%), and sore throat (81.6%); 20.1% of the patients had underlying comorbidities. Hypertension was seen in 8.8% and diabetes in 7.6% of all the cases. The percentage of cases with temperatures >38֯C was 20.3% (n = 129), and 1.6% of patients had heart rates ≥125 beats/min and 4.7% of them had respiratory rates of >24 breaths/min. Lymphocytopenia occurred in 37.5% of cases. Overall, 71.6% of patients were admitted to hospitals and 4.7% required ICU treatment. We could not completely assess the clinical courses or final outcomes of COVID-19 patients.

Conclusion: In this multi-center retrospective study, fever and cough were common symptoms. Special attention should be addressed toward asymptomatic carriers and workers in health care facilities as they play a key role in disease transmission.

Keywords: COVID-19; Clinical characteristics; Coronavirus; Outbreak; Saudi Arabia.

Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Figures

Fig. 1
Fig. 1
Patient Disposition Flowchart.
Fig. 2
Fig. 2
Distribution of COVID-19 Cases across Saudi Arabia. Distribution of COVID-19 Cases across Saudi Arabia. Centers for Disease Control and Prevention. Epi Info™, https://www.cdc.gov/epiinfo/index.html [Accessed 15 April 2020].
Fig. 3
Fig. 3
Types of symptoms reported by COVID-19 cases.

References

    1. World Health Organization . 2020. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19.
    1. MOH News . 2020. M.O.H. Reports First Case of Coronavirus Infection. March [Accessed 5 April 2020]
    1. World Health Organization . 2020. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) February [Accessed 5 April 2020]
    1. Petrosillo N., Viceconte G., Ergonul O., Ippolito G., Petersen E. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020 doi: 10.1016/j.cmi.2020.03.026.
    1. Guan W., Ni Z., Hu Y., Liang W., Ou C., He J. Clinical characteristics of Coronavirus Disease 2019 in China. New Engl J Med. 2020 doi: 10.1056/NEJMoa2002032.
    1. Jiang F., Deng L., Zhang L., Cai Y., Cheung C., Xia Z. Review of the clinical characteristics of Coronavirus Disease 2019 (COVID-19) J Gen Intern Med. 2020 doi: 10.1007/s11606-020-05762-w.
    1. Chan J., Yuan S., Kok K., To K., Chu H., Yang J. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. doi: 10.1016/S0140-6736(20)30154-9.
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5.
    1. Chen T., Wu D., Chen H., Yan W., Yang D., Chen G. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Br Med J. 2020:368. doi: 10.1136/bmj.m1091.
    1. Arentz M., Yim E., Klaff L., Lokhandwala S., Riedo F., Chong M. Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington State. J Am Med Assoc. 2020 doi: 10.1001/jama.2020.4326.
    1. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. J Am Med Assoc. 2020;323(11):1061. doi: 10.1001/jama.2020.1585.
    1. 2020. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) [Accessed 7 April 2020]
    1. Tan L., Wang Q., Zhang D., Ding J., Huang Q., Tang Y. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Tar Ther. 2020;5(1) doi: 10.1038/s41392-020-0148-4.
    1. Severance E., Bossis I., Dickerson F., Stallings C., Origoni A., Sullens A. Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan population. Clin Vacc Immunol. 2008;15(12):1805–1810. doi: 10.1128/CVI.00124-08.
    1. Müller M., Meyer B., Corman V., Al-Masri M., Turkestani A., Ritz D. Presence of middle east respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis. 2015;15(5):559–564. doi: 10.1016/S1473-3099(15)70090-3.
    1. Al Kahlout R., Nasrallah G., Farag E., Wang L., Lattwein E., Müller M. Comparative serological study for the prevalence of Anti-MERS coronavirus antibodies in high- and low-risk groups in Qatar. J Immunol Res. 2019:1–8. doi: 10.1155/2019/1386740.
    1. Singer M., Deutschman C., Seymour C., Shankar-Hari M., Annane D., Bauer M. The third international consensus definitions for sepsis and septic shock (Sepsis-3) J Am Med Assoc. 2016;315(8):801–810. doi: 10.1001/jama.2016.0287.
    1. World Health Organization . 2020. Coronavirus Disease (COVID-19) Technical Guidance: Laboratory Testing for 2019-nCoV in Humans.
    1. Goyal P., Choi J., Pinheiro L., Schenck E., Chen R., Jabri A. Clinical characteristics of Covid-19 in New York city. New Engl J Med. 2020 doi: 10.1056/NEJMc2010419.
    1. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
    1. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New Engl J Med. 2020 doi: 10.1056/NEJMoa2001316.
    1. Pan L., Mu M., Yang P., Sun Y., Wang R., Yan J. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China. Am J Gastroenterol. 2020:1. doi: 10.14309/ajg.0000000000000620.
    1. Mizumoto K., Kagaya K., Zarebski A., Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance. 2020;25(10) doi: 10.2807/1560-7917.ES.2020.25.10.2000180.
    1. Hu Z., Song C., Xu C., Jin G., Chen Y., Xu X. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020;63(5):706–711. doi: 10.1007/s11427-020-1661-4.
    1. Black J., Bailey C., Przewrocka J., Dijkstra K., Swanton C. COVID-19: the case for health-care worker screening to prevent hospital transmission. Lancet. 2020 doi: 10.1016/S0140-6736(20)30917-X.
    1. Shi H., Han X., Jiang N., Cao Y., Alwalid O., Gu J. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–434. doi: 10.1016/S1473-3099(20)30086-4.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner